Table 3.
Clinical progress & outcomes
| All (n=613) | Caucasian (n=292) | Asian (n=203) | Afro-Caribbean (n=118) | Adjusted OR/HR | Adjusted OR/HR | |
|---|---|---|---|---|---|---|
| 95% CI | 95% CI | |||||
| Asians* | Afro-Caribbean* | |||||
| Chest pain | 17.5% (63) | 12.7% (24) | 19.8% (24) | 31.9% (15) | 1.60 | 2.09 |
| 0.86-2.98 | 1.06-4.09 | |||||
| Myocardial Infarction | 3.1% (19) | 3.1% (9) | 3.0% (6) | 3.4% (4) | 0.76 | 0.92 |
| 0.21-2.80 | 0.22-3.93 | |||||
| Myocardial Injury** | 66.1% (287) | 72.1% (137) | 56.3% (90) | 71.4% (60) | 1.12 | 2.64 |
| 0.55-2.26 | 1.10-6.35 | |||||
| Acute HF | 7.2% (44) | 5.1% (15) | 6.9% (14) | 12.7% (15) | 1.72 | 3.64 |
| 0.71-4.15 | 1.50-8.84 | |||||
| Ischaemic Stroke | 2.4% (15) | 2.1% (6) | 2.5% (5) | 3.4% (4) | 0.81 | 0.66 |
| 0.26-2.56 | 0.16-2.77 | |||||
| AF episode | 7.3% (45) | 9.9% (29) | 6.4% (13) | 2.5% (3) | 0.55 | 0.25 |
| 0.24-1.30 | 0.07-0.90 | |||||
| Ventricular Tachycardia | 0.3% (2) | 0% (0) | 1.0% (2) | 0% (0) | N/A | N/A |
| Venous Thromboembolic disease | 5.5% (34) | 3.8% (11) | 8.4% (17) | 5.1% (6) | 4.10 | 1.77 |
| 1.49-11.27 | 0.52-6.07 | |||||
| Death During Admission | 33.4% (201) | 33.2% (97) | 32.7% (65) | 35.1% (39) | 1.89 | 2.03 |
| 1.24-2.90 | 1.28-3.23 | |||||
| Pneumonia | 75.4% (460) | 69.8% (20) | 82.3% (167) | 77.6% (90) | 1.90 | 1.41 |
| 1.10-3.31 | 0.77-2.59 | |||||
| Acute Kidney Injury | 36.3% (218) | 37.4% (108) | 31.6% (62) | 41.4% (48) | 0.87 | 2.11 |
| 0.51-1.49 | 1.15-3.86 |
Abbreviations: HF: heart failure;
*
Caucasian Ethnicity used as reference & OR used for all comparisons, except for survival;
**
High sensitivity troponin ≥15 ng/L, the 99th percentile of normal;
Note: Adjustment performed for: age, hypertension, type-2 diabetes mellitus, eGFR, BMI, and use of NSAIDs and Immunosupression prior to admission.